Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paul Kung is active.

Publication


Featured researches published by Paul Kung.


Archive | 2015

Small Molecules Targeting the Mitochondrial Permeability Transition

Justina Sileikyte; Sudeshna Roy; Patrick Porubsky; Benjamin Neuenswander; Jenna Wang; Michael Hedrick; Anthony B. Pinkerton; Sumeet Salaniwal; Paul Kung; Arianna Mangravita-Novo; Layton H. Smith; Dennis Bourdette; Michael R. Jackson; Jeffrey Aubé; Thomas Dy Chung; Frank J. Schoenen; Michael Forte; Paolo Bernardi


Archive | 2015

Functional Antagonists of EBI-2

Robert Ardecky; Eduard Sergienko; Jiwen Zou; Santhi Ganji; Brock Brown; Qing Sun; Chen-Ting Ma; Becky Hood; Kevin Nguyen; Stefan Vasile; Eigo Suyama; Arianna Mangravita-Novo; Sumeet Salaniwal; Paul Kung; Layton H. Smith; Thomas Dy Chung; Michael R. Jackson; Anthony B. Pinkerton; Robert C. Rickert


Archive | 2015

Allosteric Small Molecule Inhibitors of LMPTP

Robert Ardecky; Michael Hedrick; Stephanie M. Stanford; Matthew R. Bliss; Jiwen Zou; Palak Gosalia; Fusayo Yamamoto; Monika Milewski; Nikki Barron; Qing Sun; Santhi Ganji; Alka Mehta; Elliot Sugarman; Kevin Nguyen; Stefan Vasile; Eigo Suyama; Arianna Mangravita-Novo; Sumeet Salaniwal; Paul Kung; Layton H. Smith; Eduard Sergienko; Thomas Dy Chung; Anthony B. Pinkerton; Nunzio Bottini


Archive | 2015

Inhibitors of Myocyte Triacylglyceride Accumulation

Paul M. Hershberger; Eliot Sugarman; Patrick Maloney; Satyamaheshwar Peddibhotla; Ada Koo; Eigo Suyama; Manuel E. Ruidiaz; Susanne Heynen-Genel; Kevin H. Nguyen; Stefan Vasile; Arianna Mangravita-Novo; Layton H. Smith; Mangala M. Soundarapandian; Sumeet Salaniwal; Paul Kung; Rick B. Vega; Thomas Dy Chung; Anthony B. Pinkerton; Siobhan Malany; Daniel P. Kelly


Archive | 2015

Table 5, Summary of in vitro ADME Properties of EBI2 inhibitor probe ML401 (MLS-0472527)

Robert Ardecky; Eduard Sergienko; Jiwen Zou; Santhi Ganji; Brock Brown; Qing Sun; Chen-Ting Ma; Becky Hood; Kevin Nguyen; Stefan Vasile; Eigo Suyama; Arianna Mangravita-Novo; Sumeet Salaniwal; Paul Kung; Layton H. Smith; Thomas Dy Chung; Michael R. Jackson; Anthony B. Pinkerton; Robert C. Rickert


Archive | 2015

Scheme1, Synthesis of ML401, conditions: a. CDI, THF 2 to 3 hrs at RT (79%); b. DCM, TFA 0 °C; c. 4-Cl benzyl bromide, K2CO3, Acetone, 50°C 2 hours (58%)

Robert Ardecky; Eduard Sergienko; Jiwen Zou; Santhi Ganji; Brock Brown; Qing Sun; Chen-Ting Ma; Becky Hood; Kevin Nguyen; Stefan Vasile; Eigo Suyama; Arianna Mangravita-Novo; Sumeet Salaniwal; Paul Kung; Layton H. Smith; Thomas Dy Chung; Michael R. Jackson; Anthony B. Pinkerton; Robert C. Rickert


Archive | 2015

Figure 1, Structure of ML377

Paul M. Hershberger; Eliot Sugarman; Patrick Maloney; Satyamaheshwar Peddibhotla; Ada Koo; Eigo Suyama; Manuel E. Ruidiaz; Susanne Heynen-Genel; Kevin H. Nguyen; Stefan Vasile; Arianna Mangravita-Novo; Layton H. Smith; Mangala M. Soundarapandian; Sumeet Salaniwal; Paul Kung; Rick B. Vega; Thomas Dy Chung; Anthony B. Pinkerton; Siobhan Malany; Daniel P. Kelly


Archive | 2015

Figure 1, EBI2 antagonist GSK682753

Robert Ardecky; Eduard Sergienko; Jiwen Zou; Santhi Ganji; Brock Brown; Qing Sun; Chen-Ting Ma; Becky Hood; Kevin Nguyen; Stefan Vasile; Eigo Suyama; Arianna Mangravita-Novo; Sumeet Salaniwal; Paul Kung; Layton H. Smith; Thomas Dy Chung; Michael R. Jackson; Anthony B. Pinkerton; Robert C. Rickert


Archive | 2015

Figure 3, Potency of ML377 inhibition for triacylglycerol accumulation in both H9c2 cells and differentiated human skeletal myotubes

Paul M. Hershberger; Eliot Sugarman; Patrick Maloney; Satyamaheshwar Peddibhotla; Ada Koo; Eigo Suyama; Manuel E. Ruidiaz; Susanne Heynen-Genel; Kevin H. Nguyen; Stefan Vasile; Arianna Mangravita-Novo; Layton H. Smith; Mangala M. Soundarapandian; Sumeet Salaniwal; Paul Kung; Rick B. Vega; Thomas Dy Chung; Anthony B. Pinkerton; Siobhan Malany; Daniel P. Kelly


Archive | 2015

Table 4, Summary of in vitro ADME Properties of TAG inhibitor probe ML377

Paul M. Hershberger; Eliot Sugarman; Patrick Maloney; Satyamaheshwar Peddibhotla; Ada Koo; Eigo Suyama; Manuel E. Ruidiaz; Susanne Heynen-Genel; Kevin H. Nguyen; Stefan Vasile; Arianna Mangravita-Novo; Layton H. Smith; Mangala M. Soundarapandian; Sumeet Salaniwal; Paul Kung; Rick B. Vega; Thomas Dy Chung; Anthony B. Pinkerton; Siobhan Malany; Daniel P. Kelly

Collaboration


Dive into the Paul Kung's collaboration.

Top Co-Authors

Avatar

Matthew R. Bliss

La Jolla Institute for Allergy and Immunology

View shared research outputs
Top Co-Authors

Avatar

Nunzio Bottini

La Jolla Institute for Allergy and Immunology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Stephanie M. Stanford

La Jolla Institute for Allergy and Immunology

View shared research outputs
Top Co-Authors

Avatar

Rick B. Vega

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge